Ali Oğul

14PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry - lipidsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 27, 2026
First-Line Palbociclib/Letrozole Versus Ribociclib/Letrozole in Postmenopausal HR-Positive/HER2-Negative Metastatic Breast Cancer: A Retrospective Real-World Study and an Exploratory Composite Clinical-Inflammatory Risk Score.

|Mar 11, 2026
Awareness and attitudes toward cytoreductive surgery and hyperthermic intraperitoneal chemotherapy among surgical and medical oncologists.

Erkan Güler, Ali Oğul, Volkan Sayur

|Nov 26, 2025
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study.

İlknur Deliktaş Onur, Mutlu Doğan, Mehmet Akif Öztürk

|Aug 28, 2025
Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma.

Ali Alper Solmaz, Ilhan Birsenogul, Aygul Polat Kelle

|Jun 18, 2025
Importance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography heterogeneity indices in non-small cell lung cancer.

Ali Ogul, Ilhan Birsenogul, Aygul Polat Kelle

|Apr 19, 2023
Brigatinib-associated autoimmune hepatitis: A case report.

Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir

Pageof 3

Frequent Collaborators

10 joint publications

Mahmut Büyükşimşek

5 joint publications

Semra Paydaş

4 joint publications

Abdullah Evren Yetişir

3 joint publications

Mert Tohumcuoğlu